In conclusion, this study systematically elucidated that PCP achieves effective treatment of LN in the MRL/lpr mouse model through the precise modulation of the PI3K/AKT/NF-κB signaling pathway, providing solid experimental evidence for its potential as a therapeutic strategy for LN. Here, NFKB1 is linked to lobular neoplasia.